progene link sdn bhd

The team has vast experience working in local conglomerate companies (Sime Darby and Hong Leong Group) and also multi-national companies (Bio-Rad and Motorola). Our investment portfolios are mainly in technologies range from nanotechnology, biotechnology, semiconductor, ICT and other emerging technologies. Majority of the investments are in start-ups and the rest are in mid-of expansion. Some of these investments have turnovers of tens of million or hundreds of million, with profits of millions to tens of million. The team is experienced in fundraising from angel investors and venture capitalists. Company Summary 1. Founded in December 2002. 2. The company has expanded from trading businesses to investing new technology opportunities. Our associate companies have experience in dealing with corporate clients including Intel and Seagate (USA), Amkor Anam (South Korea), TDK and other Japanese corporate account, Esec (Switzerland), Infineon (Germany) and many others. 3. We have worked with University of Michigan on their proposal to jointly raise fund to form a start-up company with their Bio-Medical researchers in University of Michigan,USA. 4. One of our Technology Advisors, Professor Valentina Snitka, Director, Principal Scientist, Research Center for Microsystems and Nanotechnology, Kaunas University Of Technology, Kunas, Lithuania, is an active researcher in Biotechnology and Nanotechnology and the recipient of several EU (FP) Grants worth tens of Million Euros.